CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.82 -0.16 (-3.31%)
As of: Oct 21, 2026 · 12:16 PM EDT

CNS Pharmaceuticals (CNSP) Non-Current Debt (2025)

Updated

Analysis

CNS Pharmaceuticals (CNSP) Non-Current Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn 62.48 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 60.50 Bn
10 CNS Pharmaceuticals 2.14 Mn -40.10 Mn - 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 300,000.00
API Access

CNS Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CNSP&period=max&api_key=YOUR_API_KEY